Comparison of the Efficacy of Unilateral Biportal Spinal Endoscopy and Posterior Lumbar Interbody Fusion in the Treatment of Lumbar Degenerative Diseases
ZHANG Tongyu, ZHANG Yumin, WANG Tingting, et al
Department of Orthopedics, Puyang Hospital of Traditional Chinese Medicine, Puyang Henan 457001
Abstract 【Objective】To compare the efficacy of unilateral biportal spinal endoscopic (UBE) and posterior lumbar interbody fusion (PLIF) in the treatment of lumbar degenerative diseases.【Methods】A total of 102 patients with lumbar degenerative diseases treated in our hospital from January 2022 to June 2024 were selected and divided into observation group (n=52, receiving UBE treatment) and control group (n=50, receiving PLIF treatment) according to different surgical methods. Preoperative and postoperative visual analogue scale (VAS) score, Japanese Orthopaedic Society (JOA) score, C-reactive protein (CRP) level and erythrocyte precipitation rate (ESR) were compared between the two groups.【Results】The intraoperative blood loss and postoperative drainage volume of the observation group were less than those of the control group, and the hospitalization time was shorter than that of the control group (P<0.05). 7 days after surgery, VAS score of the observation group was lower than that of the control group, JOA score was higher than that of the control group (P<0.05). The levels of CRP and ESR in the observation group were lower than those in the control group (P<0.05). There was no significant difference in the total incidence of complications between the two groups (P>0.05).【Conclusion】Compared with traditional PLIF therapy, UBE has less blood loss, shorter hospital stay, and more significant pain relief effect in the treatment of lumbar degenerative diseases. Moreover, the complication rates of the two surgical methods are similar, suggesting that UBE is a safe and effective treatment.
2025, Vol. 42 
